350 related articles for article (PubMed ID: 22385398)
1. Differences in prescription rates and odds ratios of antidepressant drugs in relation to individual hormonal contraceptives: a nationwide population-based study with age-specific analyses.
Lindberg M; Foldemo A; Josefsson A; Wiréhn AB
Eur J Contracept Reprod Health Care; 2012 Apr; 17(2):106-18. PubMed ID: 22385398
[TBL] [Abstract][Full Text] [Related]
2. Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch.
Jick SS; Jick H
Contraception; 2006 Oct; 74(4):290-2. PubMed ID: 16982227
[TBL] [Abstract][Full Text] [Related]
3. Nondaily hormonal contraception: establishing a fit between product characteristics and patient preferences.
Levine JP
J Fam Pract; 2004 Nov; 53(11):904-13. PubMed ID: 15527729
[No Abstract] [Full Text] [Related]
4. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
Jick SS; Kaye JA; Russmann S; Jick H
Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
[TBL] [Abstract][Full Text] [Related]
5. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
6. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
[TBL] [Abstract][Full Text] [Related]
7. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
[TBL] [Abstract][Full Text] [Related]
8. Low-dose progestin-releasing contraceptives are associated with a higher pain threshold in healthy women.
Máximo MM; Silva PS; Vieira CS; Gonçalvez TM; Rosa-E-Silva JC; Candido-Dos-Reis FJ; Nogueira AA; Poli-Neto OB
Fertil Steril; 2015 Nov; 104(5):1182-9. PubMed ID: 26341277
[TBL] [Abstract][Full Text] [Related]
9. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
Tans G; Curvers J; Middeldorp S; Thomassen MC; Meijers JC; Prins MH; Bouma BN; Büller HR; Rosing J
Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
[TBL] [Abstract][Full Text] [Related]
10. Ethinylestradiol + norelgestromin: new preparation. Transdermal contraception: no tangible progress.
Prescrire Int; 2004 Aug; 13(72):123-6. PubMed ID: 15532134
[TBL] [Abstract][Full Text] [Related]
11. Use of hormonal contraceptives in relation to antidepressant therapy: A nationwide population-based study.
Wiréhn AB; Foldemo A; Josefsson A; Lindberg M
Eur J Contracept Reprod Health Care; 2010 Feb; 15(1):41-7. PubMed ID: 20136568
[TBL] [Abstract][Full Text] [Related]
12. Ethinylestradiol + etonogestrel contraceptive vaginal ring: new drug. Possibly useful in some situations.
Prescrire Int; 2006 Apr; 15(82):50-3. PubMed ID: 16604729
[TBL] [Abstract][Full Text] [Related]
13. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
[TBL] [Abstract][Full Text] [Related]
14. Progestin-only pills for contraception.
Grimes DA; Lopez LM; O'Brien PA; Raymond EG
Cochrane Database Syst Rev; 2010 Jan; (1):CD007541. PubMed ID: 20091638
[TBL] [Abstract][Full Text] [Related]
15. Progestin-only pills for contraception.
Grimes DA; Lopez LM; O'Brien PA; Raymond EG
Cochrane Database Syst Rev; 2013 Nov; (11):CD007541. PubMed ID: 24226383
[TBL] [Abstract][Full Text] [Related]
16. [Combined hormonal contraception in cycles artificially extended].
Bustillos-Alamilla E; Zepeda-Zaragoza J; Hernández-Ruiz MA; Briones-Landa CH
Ginecol Obstet Mex; 2010 Jan; 78(1):37-45. PubMed ID: 20931801
[TBL] [Abstract][Full Text] [Related]
17. Progress in contraception: new technology.
Linn ES
Int J Fertil Womens Med; 2003; 48(4):182-91. PubMed ID: 13677551
[TBL] [Abstract][Full Text] [Related]
18. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
Jick SS; Kaye JA; Russmann S; Jick H
Contraception; 2006 Mar; 73(3):223-8. PubMed ID: 16472560
[TBL] [Abstract][Full Text] [Related]
19. Provision of contraception: a survey among primary care physicians in Finland.
Sannisto T; Kosunen E
Acta Obstet Gynecol Scand; 2010 May; 89(5):636-45. PubMed ID: 20423277
[TBL] [Abstract][Full Text] [Related]
20. Newer non-oral hormonal contraception.
Bateson D; McNamee K; Briggs P
BMJ; 2013 Feb; 346():f341. PubMed ID: 23412438
[No Abstract] [Full Text] [Related]
[Next] [New Search]
